A detailed history of Mc Ilrath & Eck, LLC transactions in Danaher Corp stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 2,610 shares of DHR stock, worth $615,542. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,610
Previous 2,725 4.22%
Holding current value
$615,542
Previous $680,000 6.62%
% of portfolio
0.13%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 19, 2024

SELL
$239.25 - $280.76 $27,513 - $32,287
-115 Reduced 4.22%
2,610 $725,000
Q4 2023

Feb 05, 2024

SELL
$185.1 - $233.13 $555 - $699
-3 Reduced 0.11%
2,725 $630,000
Q3 2023

Nov 15, 2023

BUY
$233.08 - $265.59 $522,565 - $595,452
2,242 Added 461.32%
2,728 $676,000
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $14,145 - $16,343
59 Added 13.82%
486 $122,000
Q3 2022

Oct 18, 2022

SELL
$247.06 - $1507.4 $61,517 - $375,342
-249 Reduced 36.83%
427 $110,000
Q2 2022

Jul 29, 2022

SELL
$237.11 - $299.66 $250,625 - $316,740
-1,057 Reduced 60.99%
676 $171,000
Q4 2021

Feb 08, 2022

SELL
$292.08 - $329.01 $79,445 - $89,490
-272 Reduced 13.57%
1,733 $570,000
Q2 2021

Aug 09, 2021

SELL
$225.08 - $271.69 $31,511 - $38,036
-140 Reduced 6.53%
2,005 $538,000
Q1 2021

May 12, 2021

SELL
$212.38 - $245.9 $18,689 - $21,639
-88 Reduced 3.94%
2,145 $483,000
Q4 2020

Feb 05, 2021

BUY
$212.5 - $245.46 $336,812 - $389,054
1,585 Added 244.6%
2,233 $496,000
Q2 2020

Aug 04, 2020

SELL
$128.7 - $176.83 $4,633 - $6,365
-36 Reduced 5.26%
648 $115,000
Q1 2020

May 14, 2020

BUY
$121.39 - $169.05 $4,370 - $6,085
36 Added 5.56%
684 $95,000
Q4 2018

May 07, 2019

SELL
$94.85 - $109.54 $3,794 - $4,381
-40 Reduced 5.81%
648 $67,000
Q4 2017

Mar 19, 2018

BUY
$85.26 - $94.62 $58,658 - $65,098
688
688 $64,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mc Ilrath & Eck, LLC Portfolio

Follow Mc Ilrath & Eck, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.